GSK923295 as a potential antihepatocellular carcinoma agent causing delay on liver regeneration after partial hepatectomy

BACKGROUND: The clinical trials emerged centromere protein E inhibitor GSK923295 as a promising anticancer drug, but its function in hepatocellular carcinoma (HCC) remain needs to be fully elucidated, especially as chemotherapy after hepatectomy for liver tumors. We aimed to describe anti-HCC activi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Chin Med J (Engl)
Main Authors: Tang, Jia-Cheng, Wu, Ke, Zheng, Xing, Xu, Ming, Dai, Yi, Wei, Sai-Sai, Cai, Xiu-Jun
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595801/
https://ncbi.nlm.nih.gov/pubmed/30681497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000053
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker